Please wait while we load the requested 20-F report or click the link below:
https://last10k.com/sec-filings/report/1015820/000101582022000017/qgen-20211231.htm
April 2022
April 2022
February 2022
November 2021
November 2021
July 2021
July 2021
July 2021
July 2021
May 2021
Please wait while we load the requested 20-F report or click the link below:
https://last10k.com/sec-filings/report/1015820/000101582022000017/qgen-20211231.htm
Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Qiagen Nv.
Qiagen Nv's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 20-F Annual Report
Material Contracts, Statements, Certifications & more
Qiagen Nv provided additional information to their SEC Filing as exhibits
Ticker: QGEN
CIK: 1015820
Form Type: 20-F Annual Report
Accession Number: 0001015820-22-000017
Submitted to the SEC: Mon Mar 14 2022 7:22:47 AM EST
Accepted by the SEC: Mon Mar 14 2022
Period: Friday, December 31, 2021
Industry: Biological Products No Disgnostic Substances